Global Insulin Delivery Devices Market, By Product Type (Insulin Pens, Insulin Pumps, Pen Needles, Insulin Syringes, Insulin Injectors, Others), Application (Type I Diabetes, Type II Diabetes), End User (Hospitals and Clinics, Homecare, Specialty Centers), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The insulin delivery devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 25.97 billion by 2028 and will grow at a CAGR of 9.40% in the above mentioned forecast period.
Insulin is considered as a significant part of the treatment plan for all people who have Type 1 and Type 2 diabetes. The insulin delivery device is injected directly into the fatty tissues under the skin with the help of insulin pens, syringes, insulin pumps and jet injectors.
The various favorable reimbursement environment and government support in selected countries is amongst the significant factors expected to fuel the growth and demand of insulin delivery devices market. In addition, the rise in diabetic population and technological advancements in insulin delivery devices are also anticipated to push the growth in the global insulin delivery devices market over the forecast period of 2021 to 2028. Likewise, the initiation of conferences, meetings, and congresses to spread awareness regarding insulin delivery devices is also projected to lift the growth of the market. Furthermore, the collaboration of public and private sectors to meet diabetes needs as well as the favorable device insurance and reimbursement policies are also expected to act as significant factors which will flourish the growth of the insulin delivery devices market.
The rapid increase in research and development activities, rise in healthcare expenditure and the increase in diabetes-related health expenditure in emerging economies are expected to offer significant growth opportunities for the insulin delivery devices market in the forecast period of 2021 to 2028.
However, the poor reimbursement structure as well as the various issues related with the reuse of pen needles and infusion sets are estimated to limit the growth of the insulin delivery devices market, whereas, the severe shortage of endocrinologists and strict government regulations and product approvals can challenge the growth of the insulin delivery devices market.
This insulin delivery devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on insulin delivery devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Insulin Delivery Devices Market Scope and Market Size
The insulin delivery devices market is segmented on the basis of product type, application, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the insulin delivery devices market is segmented into insulin pens, insulin pumps, pen needles, insulin syringes, insulin injectors and others. Insulin pens have further been segmented into reusable insulin pens and disposable insulin pens. Insulin pumps have further been segmented into external/tethered pumps and patch pumps. Pen needles have further been segmented into standard pen needles and safety pen needles.
- The insulin delivery devices market can is segmented on the basis of application into type I diabetes and type II diabetes.
- The end user segment of the insulin delivery devices market is segmented into hospitals and clinics, homecare and specialty centers.
- Based on distribution channel, the insulin delivery devices market is segmented into hospital pharmacy, retail pharmacy, online sales and diabetes clinics/centers.
Insulin Delivery Devices Market Country Level Analysis
The insulin delivery devices market is analyzed and market size insights and trends are provided by country, product type, application, end user and distribution channel as referenced above.
The countries covered in the insulin delivery devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the insulin delivery devices market owing to the rapid rise in the diabetic population along with the accessibility of technologically advanced devices. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the strong presence of a large population base suffering from diabetes as well as the increase in awareness amongst individuals.
The country section of the insulin delivery devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Insulin delivery devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for insulin delivery devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the insulin delivery devices market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Insulin Delivery Devices Market Share Analysis
Insulin delivery devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to insulin delivery devices market.
The major players covered in the insulin delivery devices market report are BD, Medtronic, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, YPSOMED, Novo Nordisk A/S, Beta Bionics, Inc., Owen Mumford Ltd., Sanofi, B. Braun Melsungen AG, Abbott, Tandem Diabetes Care, Inc., Copernicus, Insulet Corporation, Biocon, West Pharmaceutical Services, Inc., InsuJet, SHL Medical AG, SOOIL Developments Co., Ltd., and Johnson & Johnson Services, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Insulin Delivery Devices Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.